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INTRODUCTION
Tuberculosis (TB)  is the most preventable human  infection and cause more deaths 
worldwide than any other infectious disease. Tuberculosis (TB) is the leading communicable 
disease among the ten cause of the global mortality. It caused by tubercle bacillus, known as 
Mycobacterium tuberculosis, and more rarely mycobacterium bovis whose host is human. It1 
typically affects the lungs(pulmonary TB)  but can also affect other parts as well( extra 
pulmonary),  it transmitted by air droplets of  people with the active tuberculosis TB.2
Sign and symptoms of  TB
To an extent, the sign and symptoms of active TB depends on the location of affected. 
TB disease  affect mainly in respiratory illness, but it can develop other body site. The 
sites other than respiratory  where TB can affect 
Peripheral  lymph nodes (TB lymphadenitis)
Central  nervous system (TB meningitis, Tuberculoma)
Abdominal cavity
Genitourinary system
Bones  and joints
Generalised symptoms of  TB diseases includes
 Fever
 Night sweats
 Weight loss/ loss of appitite
 Fatigue
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Symptoms and sign of  TB in lungs includes:
 Cough of at least 2 to 3 week
 Chest pain
 Haemopysis (blood in sputum)3
Transmission
Mycobacterium tuberculosis is spread by small airborne droplets in most cases (97%), 
called droplet nuclei, generated by the coughing, sneezing, talking, or singing of a person 
with pulmonary or laryngeal tuberculosis. These virulent bacilli once inhaled will stay in 
the pulmonary alveoli, where they will be phagocytosed (to envelop and destroy bacteria 
and other foreign materials). It is the primary infection may be asymptomatic. Once 
infectious particles are aerosolized, they are spread throughout a room or building by air 
currents and can be inhaled by another individual. One droplet nuclei contains no more 
than 3 bacilli. Droplet nuclei are so small that they can remain air-borne for extended 
periods of time.Introduction of M tuberculosis intothe lungs leads to infection of the 
respiratory system; however, the organisms can spread to otherorgans, such as the 
lymphatics, pleura, bones/joints, or meninges, and cause extrapulmonary tuberculosis.4
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Pathogenesis of TB
The likelihood of and timing for developing active TB disease after becoming infected with TB 
bacteria is highly variable. Some people, particularly young children and those with advanced 
immune suppression (e.g., HIV/AIDS) are highly susceptible to developing TB disease soon 
afterward (primary TB disease). 
The majority (95%) of healthy people over 5 years of age who become infected with TB bacteria 
develop latent TB infection (LTBI). Of these, a small percentage(5%) will eventually develop 
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active TB disease. TB disease that develops after a period of LTBI is known as reactivation TB 
disease. Reactivation TB disease is more likely to occ ur when a person with LTBI is or becomes 
immune suppressed.5
Diagnosis of TB
Active TB disease can be difficult to diagnose, especially in children and those who have
weakened immune systems, additional tests beyond medical examinations are required. The
following tests may be used to determine if a patient has active TB disease:
  Tuberculin Skin Test (TST)
 Chest Radiograph (X-ray)
 Sputum Smear Microscopy (SSM)
  Culture
  Polymerase Chain Reaction (PCR)
 Ultrasound
  Adenosine Deaminase (ADA)
  Erythrocyte Sedimentation Rate (ESR)
 TB LAM (lateral flow version) 6
Treatment
Drug  treatment is the keystone of  tuberculosis management. When active disease is present, a 
bare of minimum 2 drugs and generally 3 or 4 drugs must be used simultaneouly.7 The duratioin 
of tretment depends on the condition of host, extent of disease, presence of drug resistance and  
tolerence  of medication. The shortest duration of treatment is generally 6 month, and  2 to 3 
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years of treatment is necessary for cases of multi drug resistance TB (MDR – TB) . As it lomg 
term  vigilant follow up is required to improve the treatment outcome.8
FDA approved   TB treatment drugs, isoniazid (INH), rifampin (RIF), ethambutol (EMB), and 
pyrazinamide (PZA) are considered first-line anti-TB drugs and form the core of standard 
treatment regimens. Rifabutin (RBT) and rifapentine (RPT) may also be considered firstline 
drugs under certain circumstances. RBT is used as a substitute for RIF in the treatmen..9 
Amikacin and kanamycin, nearly identical aminoglycoside drugs used in treating patients with 
TB disease , are not approved by the FDA for treatment of TB. These drugs are reserved for 
special situations such as drug intolerance or resistance.10
Directly Observed Therapy (DOT)
DOT is a component of case management that helps ensure patients adhere to therapy. It is 
themethod whereby a trained health-care worker or another trained designated person watches 
apatient swallow each dose of anti-TB drugs and documents it. DOT is the preferred 
coremanagement strategy recommended for treatment of TB disease and, if resources allow, 
forlatent tuberculosis infection (LTBI) treatment. DOT can reduce the development of drug 
resistance, treatment failure, or relapse after the end of treatment. Good case management, which
includes establishing a relationship with the patient and addressing barriers to 
adherence,facilitates successful DOT.11 Nearly all the treatment regimens for drug-susceptible 
TB diseasecan be given intermittently if they are directly observed. Using intermittent regimens 
reduces thetotal number of doses a patient must take, as well as the total number of encounters 
with thehealth-care provider or outreach worker, making these regimens more cost-effective. 
Drugresistant TB disease should always be treated with a daily regimen and under direct 
observation. There are no intermittent regimens for treatment of multidrug-resistant (MDR) TB. 
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If anti-TB drugs for the treatment of MDR TB need to be given twice daily, then DOT should be 
provided twice daily as well.12
Drug resistant Tuberculosis (MDR-TB & XDR-TB)
The bacteria that cause TB can develop resistance to the antimicrobial drugs used to cure the 
disease. Multidrug-resistant TB (MDR-TB) is TB that does not respond to at least isoniazid and 
rifampicin, the two most powerful anti-TB drugs. The reasons why multidrug resistance 
continues to emerge and spread are mismanagement of TB treatment and person-to-person 
transmission. Most people with TB are cured by a strictly followed, six-month drug regimen that 
is provided to patients with support and supervision. Inappropriate or incorrect use of anti-
microbial drugs, or use of ineffective formulations of drugs (e.g. use of single drugs, poor quality 
medicines or bad storage conditions), and premature treatment interruption can cause drug 
resistance.13 Extensively drug-resistant TB,( XDR-TB) is a form of multi  drug resistant TB with 
additional resistance to more anti-TB drugs that therefore responds to even fewer available 
medicines.14
BACKGROUND
Estimates show that approximately one third of globel population of the world continuously 
infected  with Tuberculosis. The World Health Oranisation (WHO) reported that,  TB is almost 
exclusively a disease of the developing countries.15 According to World health organisation 
(WHO), by the end of 2020, nearly one billion people will newly infected, 200 million people 
get sick and 35 million will die feom tuberculosis,if control is not further strengthened16
Every day in india, under the Revised Nat ion TB Control  Programme(RNTBCP),  more than 
15,000 people were examined. Erstimate suggest that two persons die every three minutes due to 
tuberculosis and 5000 new cases TB cases are diagnosed per day.A single patient can infect 10- 
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15 people in a year. 17  The  availabilitybof effective treatment, TB  still a major health problem 
in most countries. The poor out-come was accredited to poor adherence, and partly due to  
adverse drug reaction. Non –complaince is cited as a major obstacle to the control of 
tuberculosis  at the level of public health. It is also a serious problem in the tratment of individual 
patients and  in the development of  drug resistant stains.18
Medication adherence/ complaince are similar terms. Complaince  is extend to which the 
patient’s medication taking behaviour coincides with medical or  health advice; and persistence 
as the duration of  time  from initiation  to discontinuation of therapy. 19 Non – adherence to TB 
treatmen t leads to high increase in morbidity and  mortality, prolonged TB infectiousness, multi 
drug resistance, relapse and death. The patient with adherence  level grater than  90%  facilitate 
cure. The failure of cure increase the risk of development of drug  resistant stains and further 
spread  TB in the community.20
After several decades of reserch  show that medication non-adherence is  due to many factors 
including lack of adequate knowledge about medication and treatment goals, beliefs about 
medication, complex regimes that are difficult to manage, side effects and costs associated with 
medications.21
According to world health organisation , the reason for poor complaince with anti-tuberculosis 
treatment in developing  countries are complicated . 22 that includes; the characteristics of the 
individual patient, communication between the patients and healthcare providers, social and 
economic factors such as availability of drug, duration  and number of medication , side effects, 
cost of treatment, competing demands on time23. However , patient adherence to tuberculosis 
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treatmen t require the active participation of the patient  in self management of  treatment and 
cooperation  between patient and the health care provider.24
ROLE OF PHARMACIST IN ATT-AS A PART OF HEALTH CARE TEAM
Educating patients about TB disease helps ensure their successful completion of therapy. 
Healthcare providers must take the time to explain clearly to patients what medication should be 
taken, how much, how often, and when. Patients should be clearly informed about possible 
adverse reactions to the medications they are taking and when to seek necessary medical 
attention. Providing patients with the knowledge they need regarding the consequences of not 
taking their medicine correctly is very important. In addition, patients should be educated about 
infection control measures and potential need for isolation.25
All health care providers need to counsel TB patients not only the importance of taking their 
medication regularly but also on the importance of  completing their course of treatment. Poor 
adherence with TB treatment is more dangerous than no treatment as it may increase the risk of 
developing multi drug resistant tuberculosis strains. 26
  Patient understanding of their treatment regim can influence their adherence 
behavior.Pharmacists can play a pivotal role in promoting patient adherence to drug therapy, 
which leads to optimization of drug therapy goals and outcomes. (27, 28) As medication experts, 
pharmacists can utilize their clinical training to reduce drug interactions, optimize therapy for 
patients presenting resistant microbes, provide education on the importance of adherence to 
therapies, and make recommendations for therapy when necessary.29
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Here come the role of pharmacist. Clinical pharmacist has the responsibility to identify, prevent 
and resolve medication related problems.  The services given by the clinical pharmacist include 
medication history interview, medication order review, providing drug information, assessment 
and management of drug interaction, patient medication counseling and management of  ADR’s 
which will improve patient compliance and reduce health care costs.30
The pharmacist should educate patients on the importance of continuing their chemotherapy 
despite symptomatic improvement. Pharmacist should become a part of multidisciplinary band 
devoted to successful chemotherapy of TB patient and their families.31
. 
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 LITERATURE REVIEW
 Xinji Gong, et al., (2018 ) conducted a study on “Treatment adherence among 
sputum smear-positive pulmonary tuberculosis patients in Xinjiang, China”it 
was  a prospective study was conducted for   total of 8289 sputum smear 
positive TB patients were included . Among 8289 patients, 3827 men (84.4% 
of male patients) and3220 women (85.7% of female patients) had good 
adhence during treatment follow-up. 1242 patients(15.0%) did not complete 
regular follow-up. 332 (4 .0%) patients lost contact. The concluded with 
supervision and interventions during the TB treatment process to improve 
patient adherence to anti-TB treatment 32
 Jaramillo E, et al. (2018)  conducted a study on “Adherence interventions and 
outcomes of tuberculosis treatment: A systematic review and  metaanalysis of 
trials and observational studies.” in this 129 met the inclusioncriteria for 
quantitative analysis. Seven adherence categories were identified the study      
concluded that, TB treatment outcomes are improved with the use of adherence 
interventions, such as patient education and counseling, incentives and 
enablers, psychological interventions, reminders and tracers, and digital health 
technologies. hThis concluded with Trained healthcare providers as well as 
community delivery provides patient-centered DOT options that both enhance 
adherence and improve treatment outcomes as compared to unsupervised,33
 Aarsha Joby et al., (2017) conducted a study on the topic “Impact of  
pharmacist assisted Patient counseling For  improving medication adherence 
and quality of life in pulmonary tuberculosis patient” it was a interventional 
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prospective study. In the study 164 patients enrolled there were 2 deaths and 5 
drop outs. Among 157 patients , 37 were found to be a adherent 20 were at the 
risk of non-adherence  and 100 were found to be non adherent. The study 
concluded that , pharmacist assisted patient counseling had a significant impact 
in improving medication adherence and QOL in pulmonary tuberculosis 
patients.34
 Khairunnisa et al.,(2017) conducted a study on the topic “ Pharmacist’s 
perception about their roles in tuberculosis control program in medan, 
Indonesia” in this study involved 117were asked to choose answering yes, no 
or do not know for their perception on their roles in TB control program. . 
Mean age of the participants was 38.6±11.7 (years). Most of them  were 
female. Distribution of the participants by place of practice: Pharmacy, 78.6%; 
hospital, 20.5%. Most of them (63.2%) have heard about directly observed 
treatment short-course program. More than 90% of them realized that they 
could play their roles as providers, managers of anti-TB drugs, drug 
informants, ensurers for adherence to the TB treatment, educators for patients 
and publics on TB and its treatment. Only 26.5% of them knew that they could 
also play their role as inventors of early suspected TB in the community. The 
study  Concluded that, pharmacists’ roles could be utilized and enhanced to 
optimize TB control programs in Indonesia.35
 Aline Ale Beraldo et al., (2017) conducted a study on” Adherence to 
tuberculosis treatment in Primary Health Care: perception of patients and 
professionals in a large municipality” it was a Cross-sectional epidemiological 
study conducted at the PHC of Campinas-SP, through structured interviews 
Literature Review
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with 18 corresponding questions on the perception of professionals (183) and 
patients (165).  The study Concluded that, The identification of gaps in the 
offer of actions for adherence to TB treatment can help health services to 
change and improve the practice and the epidemiological scenario of the 
disease.36
 Rohit et al., (2017) conducted  a study on “Determine the factors influencing 
DOTS Compliance among tuberculosis patients of selected DOTS Centers of 
Ludhiana, Punjab.” the  study carried out in selected DOTS centers.Total 110 
tuberculosis patients taking DOTS were chosen by Purposive sampling 
technique. Self structured checklist was used to determine the factor 
influencing DOTS compliance among tuberculosis patients. It concluded that 
self motivational factor had the highest influence on compliance to DOTS but 
economical factors were influenced not to comply with DOTS and in context 
to factors compliance, it was not affected by socio demographic variables.37
 Harshul Gohel et al., (2017) conducted a study on “A Cross Sectional Study 
to Assess the Non-Adherence to Anti-TuberculosisTreatment and Determinant 
Factors among Patients with Pulmonary Tuberculosis” in this  adherent and 
non-adherent patients randomly selected from government hospital and private 
hospital were interviewed using pre structured questionnairesmos t frequently 
mentioned reason for non-adherence to treatment was taking treatment from 
goverment hospital. The study indicated that patients who had low level of 
education, frequently travelling were showing non- adherent to treatment. 
Treatment adherence of TB patients receiving treatment in private hospital 
might be improved by providing health education about treatment duration and 
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side effects, facilitating procedures for  receiving treatment free of charge and 
reducing costs of transportation and consultation. Qualified friendly health care 
staff able to motivate patients might further improve adherence in government 
hospital. 38
 Andrés Noe et al., (2017 ) conducted a study on” Knowledge, attitudes and 
practices regarding tuberculosis care among health workers in Southern 
Mozambique”it was a descriptive cross-sectional study was performed through 
the use of a specifically designed Knowledge, Attitudes and Practices (KAP) 
questionnaire. the study concluded that, present study provides impetus for 
tailored TB education among health care workers from a high TB burden rural 
area in Southern Mozambique.39
 Richard Kiplangat Arap Sang et al.,  (2017) conducted a study on “Patient 
Factors Which Contribute to Non-adherence to TB Treatment in Kericho and 
Nakuru Counties of Kenya” The study concludes that Patient factors leading to 
non adherence range from Feeling well soon after medication, Alcoholism, 
self-denial, Drug side effects, pill burden, lack of food and low educational 
level. These are factors that are patient centered. Solution lies in patient Health 
Education that will lead to behaviour change that directly affects the patient’s 
adherence to Tuberculosis treatment.40
 S. O. Oyugi et al.,(2017) conducted a study on Patient factors influencing 
adherence to anti-tuberculosis medication in njoro sun county hospital, 
keneya” In this  study 25 patients analyzed. The study concluded that, t about a 
quarter of patients in TB treatment program will at one point miss some pills 
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either due to Conflict with work schedule, poor relationship between patients 
and Health Care Providers and alcoholic.41
 Siddiqua Aamiret al., (2016) conducted a study on “Role of Counselling to 
Facilitate Compliance to the Dots for the Treatment of Tuberculosis” in the 
study included 60patient diagnosed with pulmonary tuberculosis. The  
sampling technique was used for the assignment of the patients to the 
experimental group (n= 30) and a control group (n=30).  The results indicated 
that the majority of the experimental group patients adhered to the therapy. The 
study Concluded that, Counseling of patients is important to optimize therapy, 
aid compliance and to inform patients’ of any potential complications of 
therapy.42
 Vijayalakshmi et al. (2016) conducted a study on   “A prospective study on 
abnormal liver function test patterns in patients receiving anti-tubercular 
therapy” in this study assessed the incidence and risk factors of anti-TB-DIH . 
the patient enrollment was  63 are males and 37  are females, results shows 
that, Comparison between before treatment and 2 months treatment showed a 
significant increase .study concluded that, Anti-TB-DIH is not uncommon, 
needs early recognition and treatment and is more in patients with pre-existing 
liver disease and lower body mass index. in the level of aspartate amino 
transferase  (AST),  alanine amino transferase (ALT), and alkaline phosphatase 
(ALP).43
 Yohannes Zenebe et al., (2016) conducted a study on”Profile of tuberculosis 
and its response to anti-TB drugs among tuberculosis patients n treated under 
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the TB control program at Felege-Hiwot Referral Hospital, Ethiopia” in this 
analyzed the records of 1761 TB patients registered for treatment.  And 
Concluded that,: In the studied region, the overall treatment success rate was 
still below the WHO target of success rate, 85 %. However, the trend of 
treatment success rate showed a promising increment. Patients at high risk of 
unsuccessful treatment outcome should be identified early and given additional 
follow-up, medical interventional social support.44
 Stephanie Lin et al.,(2016)  conducted a study on “Systematic review of risk 
factors for non adherence to TB treatment in immigrant populations “in this 
1761 studies identified in the search, 20 were included in the risk factor 
review. Undocumented immigration status, older age, and social risk factors 
were consistently correlated with non adherence  gender, ethnicity, 
immigration time, education level, adverse side effects, and HIV status were 
inconsistently correlated; and behavioural risk factors and marital status were 
consistently not correlated. Which concluded, the  review emphasizes 
documentation status as a risk factor candidate for further investigation. 45
 Shrishail S Patil et al., (2016) conducted a study on “A Study on Assessment 
of Patients Health Related Quality of Life During Tuberculosis Treatment in 
Tertiary Care Teaching Hospital”. the  study was conducted for total 70 
patients (56 men and 14 women) diagnosed with tuberculosis. A total of 70 
patients completed the SF-36v2 questionnaire at the start of their treatment. 
Out of these, 53 and 41 completed the questionnaire at the second and third 
follow-ups, respectively. The study concluded with HRQoL improved with the 
treatment, the scores on component summary measures revealed the 
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improvement of both physical and mental health among study patients at the 
end of intensive phase. 46
 Daniel Fleissner et al., (2016) conducted a study on “The Impact of 
Pharmacist-Delivered Patient Education on Tuberculosis Drug Therapy 
Adherence”. The study concluded that pharmacist-led patient education and 
therapy monitoring increase adherence to prescribed treatment regimens and 
treatment completion rates. 47
 Jeremiah Chakaya et al.,(2016)conducted a study on “Long term 
complications after completion of pulmonary tuberculosis treatment” the study 
concluded that, the long term complications that follow treatment of 
pulmonary TB is long overdue and will significantly contribute to the quality 
of care for TB patients. In many PTB patients successful completion of TB 
treatment or bacteriological cure is not the end of the need for care.48
 Evans Dans et al., (2015) conducted a study on “ Patients’ Compliance with 
Tuberculosis Medication in Ghana Evidence from a Periurban Community” 
this study focused on Wide disparity in background characteristics between 
patients and their treatment supporters can affect acceptance of health 
directives provided by the treatment supporter. The results show that males 
who were previously treated  were more than females . this study concluded 
with treatment supporters should be galvanized more in order to ensure a better 
control of the disease. Patients’ noncompliance with medication in the district 
is an issue and requires new approaches to solve the problem27
Literature Review
 17
Department of Pharmacy Practice
 .Muhammad Atif, et al., (2014) conducted a study on Impact of tuberculosis 
treatment on health-relatedquality of life of pulmonary tuberculosis patients. 
This was a prospective follow-up of new smear positive PTB patients who 
were diagnosed at the chest clinic of Penang General Hospital  between March 
2010 and February 2011. All eligible patients (i.e., a new case of smear 
positive PTB, literate and aged 18 years or above) were asked to self-complete 
the SF-36v2 questionnaire atthe start of their treatment, and then subsequently 
after the intensive phase and at the end of the treatment. A total of 216 patients 
completed the SF-36v2 questionnaire at the start of their treatment .The study 
concluded that the  HRQoL improved with the treatment, the scores on 
component summary measures showed compromised physical and mental 
health among study patients even at the end of their TB treatment.17
 Mudegoudara Lingaraja et  al., (2014) conducted a study on “A Study of 
Liver Function Tests Abnormalities in Tuberculosis Patients Under RNTCP-
DOTS, VIMS Bellary”. The  purpose of the study was to evaluate the 
incidence of drug induced hepatitis.  enrolled of 107 patients, 56(52.33%) were 
males and 51(47.66%) were females. The study conclude that the incidence of 
DIH is more common in patients with malnutrition, old age and advanced 
pulmonary tuberculosis . 49
 Allumellu Venkatapraveen, et al.,( 2013)conducted a study on the Topic 
“Assessment of clinical pharmacist intervention to improve compliance a 
health care outcomes of tuberculosis patients. The nine months prospective 
study was conducted and enrolled patients were randomly divided in to two 
groups i.e. Intervention and Control groups. Out  of 120 patients enrolled, 114 
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patients completed the study. Among 114 patients 81 were males and 33  were 
females. Comparatively the knowledge and drug adherence score of the 
Pulmonary Tuberculosis (PTB) patients of intervention group shows more 
improvement from baseline to I and II Follow ups which is statistically 
significant than the control group. The study concludes that pharmacist 
provided patient education found to have significant influence on patients 
compliance and health care outcomes.19
 Mukhtar A. Solliman  et al(2012) conducted a study on ”Assessment of 
Knowledge towards Tuberculosis among general population in North East 
Libya” it was a  cross sectional study and  pre validated questionnaire 
consisting of 23 items was sent to 1500 residents among five cities This study 
reveals that knowledge towards TB within the population is poor. It is 
therefore suggested that specialized educational programs should be developed 
for community members to promote awareness towards TB.50
 Daftary, et al.,(2011)Performed  a study on “Adherence to treatment for latent 
tuberculosis infection. A systematic review of studies in the USand Canada” 
was undertaken to analyze measurement ofadherence to treatment of LTBI 
(TLTBI), TLTBI completionrates, predictors of TLTBI adherence and 
TLTBIadherence interventions. Associations between adherence and patient 
factors,clinic facilities or treatment characteristics were found tobe inconsistent 
across studiesA ‘one-size-fi tsall’approach to treatment for TLTBI adherence is 
notlikely to succeed across all settings. Innovative approachescan inspire future 
interventions and suggest solutions forthe current problems facing LTBI 
programs and their patients. 51
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 Monica G Amuha et al., (2009) conducted a study on “Non-adherence to anti-
TB drugs among TB/HIV co-infected patients in Mbarara Hospital Uganda: 
Prevalence and associated factors”. The study select 140 participants. study 
concluded that, The prevalence of non-adherence was high. Patients that are on 
continuous phase of TB treatment should be supported to continue taking their 
drugs. In addition, patients that drink alcohol; smoke and those not on ART 
should be targeted with interventions to improve adherence 52
 Salla A. Munro, et al., (2007) conducted a study on Patient Adherence to 
Tuberculosis Treatmentthis systematic review of qualitative studies was to  
understand the factors considered important by patients, caregivers and health 
care providers in contributing to TB medication adherence. The findings of  
review could help inform the development of patient-centred interventions and 
of interventions to address structural barriers to treatment adherence.53
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                                                        AIM
To study the effectiveness of tuberculosis medication therapy adherence clinic at KMCH
         OBJECTIVE
฀ To assess the level of adherence of anti-TB treatment
฀ To identify factors associated with non-adherence
฀ To identify adverse effect or complication  resulting from the anti-TB 
medication
฀ To educate and encourage patients/ caregivers on the appropriate use of 
anti-TB medication and self- care devices
฀ To increase patients adherence towards anti-TB medication
Methodology
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3. METHODOLOGY
STUDY DESIGN:
A hospital based prospective observational study
STUDY SITE:
The study was conducted at the Department of pulmonology, Kovai Medical Center 
and Hospital, a 750 bedded multi-disciplinary advanced super speciality hospital, 
Coimbatore, Tamil Nadu, accredited by National Accreditation Board for Hospitals 
and Health care.
STUDY PERIOD:
The study was conducted from the period from February 2018 to July 2018.
STUDY POPULATION:
A total
STUDY CRITERIA
Tuberculosis patients in department of medicine were enrolled in to the study by 
considering following inclusion and exclusion criteria
INCLUSION CRITERIA:
฀ Patients diagnosed with pulmonary tuberculosis and extra pulmonary 
tuberculosis
฀ Patient between 18 year to 80 year of age
฀ Patients with active or inactive tuberculosis taking anti-tuberculosis treatment
Methodology
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      EXCLUSION CRITERIA:
฀ Patient referred to DOT’s centre
฀ Patients with MDR TB
SOURCES OF DATA:
฀ Data collection form
฀ Treatment charts
฀ Medication adherence assessment questionnaires (MMAQ)
฀ Knowledge assessment questionnaires (KAQ)
฀ Patient information leaflet (PIL)
STUDY PROCEDURE
Implementation 
 A minimum of three session of TB-MTAC are required for every patient. Subsequent 
visit follow up after 3 sessions must be done when necessary for better understanding 
on medication therapy adherence.
Baseline visit: At the initial visit, the pharmacist will perform an initial assessment of 
the patient/caregiver. The initial assessment will entails the patient socio demographic 
characteristics.
Second Follow up: 15th day after the baseline visit.
Third Follow up: 30th day after second follow up.
Missed Appointment
Patient/caregiver will contacted by phone for appointment rescheduled.
                                                                                                      Results
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RESULTS 
The study was carried out in the Pulmonology  department of Kovai medical center and hospital 
at Coimbatore, over a period of 6 months from February to July 2018. A total of 100 patients  
were enrolled in to the study. Out of which, 80 patients have completed the study. Of the whole 
population 52 (65%) were outpatients and 28 (35%) were inpatients [Tab 1, Fig 1]. Among the 
total population, 61 (76%) were male and 19 (24%) were females [Tab 2, Fig 2].it is found that 
males were more prone to tuberculosis when compared to females.
The age group analysis of entire population in the study shows that the most prominent group 
was ‘46-60’ comprising of 33 (41%) patients. 20 (25%) were between the age group of ‘61-75’ 
years of age; 18 (23%) were between the age group of ’31-45’years of age; 9 (11%) were 
between the age group of ’16-30years of age [Tab 3 Fig 3]. Over all the study shows that the 
most prominent age for the occurrence of TB was 46-60. Out of the study population, 41 (52%) 
patients were .having the smoking habit. 39 (48%) patients were non-smokers.[Tab 4 , Fig 4]. 
Among the total population 73 (91%) were married and 7(9%) patients were single. [Tab 5 , Fig 
5]. Summarized forms of TB diagnosis of the study were illustrated in table [6] and figure [6]. 63 
(78.8%) patients were diagnosed as pulmonary TB in the study population. Of the remaining 
patients in the study 11(13.8%) patient were found to have TB in Pleural, 3 (3.8%) patients were 
found to have TB in Meningitis, 2 (2.5%) patients were found to have TB in Rib, 1(1.2%) 
patients was found to have TB in lymph. It shows that when compared to EPTB,
PTB shows most occurrences.
Among the population of the study, 6(7.5%) of the patients having university  education, 18 
(22.5%) of the patients having pre-university education;31(38.8%)of the patients having school 
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level of education and 25(31.2%) of the patient were illiterate patients.[Tab.7, Fig 7]. Among the 
enrolled patients most of the patients were farmer 20 (25%) followed by daily wager 17(21.2%); 
in privet service having 13(16.2%) of the patients; 11(13.8%) of the patients in business; 3 
(3.8%)of  the patient were students; 16 (20%) of  the patient were unemployed .[Tab 8, Fig 8]
Out of the total study population, most of the patients 58 (72.5%) shows the symptom of 
persistent cough for many days followed by fever for  42 (52.5%) patients, 19 (24%) patients 
having haemoptysis chest pain for 24 (30%) patients,30(38%) of them having symptom of loss 
of appetite , 32 (40%) patients shows weight loss, 27 (34%) patients showed breathing difficulty 
and 18 (23%)  shows the other symptoms.[ Tab 9, Fig 9]. 
Among the population most of the  reason for  non-adherence are forgetfulness 21(26.25%),20 
(25%) of them having feeling well,13 (16.25%) of them reported phase of chemotherapy,8(10%) 
patient  reported side effects are reason for non-adherence, 10 (12%) reported additional drug is a 
factor for non-adherence, and the 8(10%) reported financial issue is reason for non-adherent. 
[Tab 10, Fig 10]. Among the study population 21 (26%) patients experienced at least one ADR 
during the time of study period [Tab 11, Fig 11]. Out of 21 ADR 8(38%) were elevated liver 
enzyme, which is most prominent followed by skin rash 6(28.6%), abdominal pain 3(14.3%), 
numbness of feet also 3(14.3%) and chest pain with 1(4.8%) patient. [Tab12, Fig 12].
The time interval between start of therapy and onset of ADR is given in the table [Tab 13, Fig 
13] it found that 15(71.5%) ADR occurred within the first visit after starting the therapy,  in  
second visit 4(19%) patients developed ADR and third visit 2(9.5%)patients developed. An 
overview shows that as there is a decreased  incidence of ADRs when the days get increased.
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All the 80 patients of the study were initially provided MAS questionnaires at the time of 
enrollment and subsequent follow up, medication adherence score was evaluated at baseline, first 
and second follow up. [Tab14, Fig 14]. The baseline adherence data was compared with first and 
second follow up adherence data  using  ANOVA.
The baseline with first follow up revealed a mean increase in medication adherence level of 1.95 
± 0.745 and (P <0.0001) which is statistically significant.
Baseline adherence with second follow up adherence data shows a mean increase in medication 
adherence level of 2.14 ± 0.725 and (P<0.0001) which is statistically significant. [Tab 15, Fig 
15,Fig 16]. The association of demographic characteristics of the study with adherence 
score.[Tab.16] among them except education’ all the characteristics statistically significant with 
Medication Adherence score at 0.05 significant levels. They include the participants’ gender with 
P- value of .00, age group with P- value of .003,Type of TB with P- value of .000, Marital status 
with P value of .000, patient type with P value of .000, smoking habit with P value of .000, 
Occupation with P value of .000.these are significant association between adherence. There is no 
association between Adherence on level of educational respondents. 
The knowledge score was evaluated at baseline, first and second follow up.[Tab 17, Fig 17]. The 
baseline knowledge data was compared with first and second follow up Knowledge data using 
ANOVA. The baseline knowledge with first follow up knowledge data shows a mean increase in 
knowledge level of 1.98 ± 0.675 and (P= 0.021) which is statistically significant. Baseline 
knowledge with second follow up knowledge data shows a mean increase in knowledge level of 
2.40 ± 0.722 and (P 0.009) which is statistically significant  [Tab 18, Fig 18, Fig 19]. The result 
of analysis of the relationship between Knowledge on demographic characteristics of 
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respondents. [Tab19]. Among them, all the respondents statistically significant with the TB 
Knowledge at the 0.05 significant levels. Comparatively study of  the knowledge and drug 
adherence score of the Tuberculosis patients shows more improvement from baseline to 1 and 2 
follow ups (P <0.0001). which is statistically significant.[Tab 20, Fig 20].
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                                                      DISCUSSION
In the prospective study, A total of 80 patients were incorporated in the study. 61 (76.%) were 
male and 19 (24%) were females. It found that males more prone to tuberculosis when compared 
to females. A study conducted by Mahmood et al., reveals that the pervasiveness of tuberculosis 
is more in males than females.9 Also a study performed by Jaggarajamma k et al., has the 
identical outcome alike to this study in case of the gender wise occurrence of the TB, which 
contributes that a 7:2.5 ratio of males and females incidence of TB. Not only these studies some 
other studies also point out that the TB is more prone to male gender.54 
The age group analysis of the  study shows that, 33 (41.2%) patients came under the age group of 
46-60 years which indicate the occurrence of TB more in this age group. Allumellu 
Venkatapraveen et al., observed that 27(24%) patients had TB in the age group of 51-60 years.19 
A descriptive study executed by Habibullah K et al., reveals that the age group of TB occurrence 
is 45-55 years. Both of these studies supporting to the current study outcome.55 63 (78.8%) 
patients were diagnosed as pulmonary TB in the study population. About 92% of the population 
in the research of Jggarajamma K et al.,54 were diagnosed as PTB. A study reported by 
S.Lakshmi Sabapathi1 et al., interpret that 74% of the study population were diagnosed PTB 
which is matching to this study.56 
Out of the total study population, most of the patients 58 (72.5%) shows the symptom of 
persistent cough for many days. About 83% of patients were having cough in the study done by 
Bello and Itiola O A et al.,1 Among the population most of the  reason for  non-adherence are 
forgetfulness 21(26.25%). A study conducted by S.Lakshmi Sabapathi1 et al., reveals that the 
34% of patients shows the forgetfullness was a reason for non-adherence.56 Some of the studies 
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also  shows that the feeling well is a reason for non-adherence. 15(71.5%) ADR occurred within 
the first visit after starting the therapy , An overview shows that as there is a decreased  
incidence of ADRs when the days get increased. This is quite similar to the study of Kheirollah 
G et al.,57
Medication adherence score was evaluated at baseline, first and second follow up. Baseline 
adherence with  first  follow up and second follow up adherence data shows a mean increase in 
medication adherence. It is very similar to the study conducted by Alok bhardwaj et al., 58 and 
study conducted by  Allumellu Venkatapraveen et al., The relationship between Adherence 
score and demographics, among them except education’ all the characteristics statistically 
significant with Medication Adherence score at 0.05 significant levels. 19A study conducted by 
Tesfahuneygn et al., reveals that the association of demographic and adherence score which 
shows there is no association between adherence and the respondents of  educational status, 
marital status.59 And the other respondents were significant with adherence score. The another 
study conducted by Tola et al observed that, the demographics  sex, education level, marital 
status, economic status, knowledge level, and psychological distress were significant with 
adherence score. But the age analysis shows there is no association between the adherence 
score.60
The knowledge score was evaluated at baseline, first and second follow up.  A study conducted 
by Allumellu Venkatapraveen et al., which also similar to  current study.19 Lekhraj Rampal et 
al., conducted a study similar to this study.61The result of analysis of the relationship between 
Knowledge on demographic characteristics of respondents. Among them, all the respondents 
statistically significant with the TB Knowledge. A study conducted by Nwankwo Mercy 
Chineye et al., which show that the  Knowledge relationship with socio-demographics 
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characteristics, among them were three that were statistically significant with knowledge at the 
0.05 significant level.62 Another study conducted by Kelemework Abera et al., which has the 
identical outcome alike to this study.63
Comparatively the knowledge and drug adherence score of the Tuberculosis patients shows more 
improvement from baseline to 1 and 2 follow ups (P <0.0001). which is statistically significant. 
Similar study was carried out by Allumellu Venkatapraveen et al., in this study patien t had 
higher score in knowledge and adherence.19 Another study conducted by Gabrieia fagundez et 
al., which   is similar to this study. 64
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  TABLES AND GRAPHS
TABLE1: WARD WISE DISTRIBUTION OF TOTAL PATIENTS (n=80)
Type of patient Frequency Percentage
Inpatient 28 35%
Out patient 52 65%
Total 80 100%
             FIGURE1:WARD WISE DISTRIBUTION POF TOTAL PATIENTS(n=80)
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TABLE2: GENDER WISE DISTRIBUTION OF TOTAL PATIENTS(n=80)
Gender Frequency Percentage
Males 61 76.2%
Females 19 23.8%
Total 80 100%
FIGURE2:GENDER WISE DISTRIBUTION OF TOTAL PATIENTS (n=80)
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 TABLE3: AGE WISE DISTRIBUTION OF PATIENT (n=80)
Age group Frequency Percentage
16-30 9 11.25%
31-45 18 22.5%
46-60 33 41.25%
61-75 20 25%
Total 80 100%
      FIGURE3: AGE WISE DISTRI   BUTION OF TOTAL PATIENTS(n=80)
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TABLE4:SMOKING HABIT OF TOTAL PATIENTS (n=80)
Smoking  habit Number of patient Percentage
Smokers 41 51.2
Non-smokers 39 48.8
Total 80 100%
  
FIGURE4: SMOKING HABIT OF TOTAL PATIENTS (n=80)
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TABLE5: MARITAL STATUS OF THE PATIENTS (n=80)
STATUS No.of patiets Percentage
Married 73 91.2%
single 7 8.8%
Total 80 100%
FIGURE5: MARITAL STAUS OF PATIENTS (n=80)
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TABLE6: TYPES  OF TUBERCULOSIS DIAGNOSED (n=80)
Type of TB Frequency Percentage
Pulmonary TB 63 78.8%
Pleural TB 11 11.8%
Rib TB 2 2.5%
Meningitis TB 3 3.8%
Lymph TB 1 1.2%
Total 80 100%
 
FIGURE6: TYPES OF TUBERCULOSIS DIAGNOSED (n=80)
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TABLE 7: EDUCATIONAL STATUS OF TOTAL PATIENTS (n=80)
Education Frequency Percentage
Illeterate 25 31.2%
School 31 38.8%
Pre-university 18 22.5%
University 6 7.5%
FIGURE 7: EDUCATIONAL STATUS OF TOTAL PATIENTS(n=80)
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TABLE 8:  OCCUPATIONAL STATUS OF TOTAL PATIENTS(n=80)
Occupation Frequency Percentage
Daily wager 17 21.2%
Student 3 3.8%
Business 11 13.8%
Farmer 18 22.5%
Unemployed 18 22.5%
Privet services 13 16.2%
Total 80 100%
FIGURE 8: OCCUPATIONAL STATUS  OF TOTAL PATIENCE(n=80)
Tables & Graphs
 38
Department of Pharmacy Practice
TABLE 9: SIGN AND SYMPTOMS OF TOTAL PATIENTS (n=80)
    
FIGURE 9: SIGN AND SYMPTOMS OF TOTAL PATIENTS (n=80
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   Symptoms Frequency Percentage
Cough 58 72.5%
Breathing difficulty 27 34%
Chest pain 24 30%
Fever 42 52.5%
Loss of appetite 30 38%
Weight loss 32 40%
Haemoptysis 19 24%
Others 18 23%
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TABLE10: REASON FOR  NON-COMPLIANCE (n=80)
Reason No of patients Percentage 
Forgetfulness 20 25%
Financial 8 10%
Side effects 8 10%
Phase of chemotherapy 13 16.25%
Additional drug 10 12.5%
Feeling well 21 26.25%
FIGURE10: REASON FOR  NON-COMPLIANCE (n=80)
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TABLE 11: DISTRIBUTION OF PATIENTS WHO DEVELOPED ADR (n=80)
FIGURE  11: DISTRIBUTION OF PATIENTS WHO DEVELOPED ADR (n=80)
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TABLE 12: TYPE OF ADR DEVELOPED (n=21)
ADR Occurence Frequency Percentage
ADR developers 21 26.26%
ADR non-developers 59 73.75%
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S.NO TYPE OF ADR FREQUENCY PERCENTAGE(%) 
1 Abdominal pain 3 14.3% 
 2 Skin rashes 6 28.6% 
3 Chest pain 1 4.8% 
4 Vomiting/
Elevated liver 
enzyme 
8 38% 
5 Numbness of feet 3 14.3% 
FIGURE 12: TYPE OF ADR DEVELOPED (n=21)
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TABLE 13: DEVELOPMENT OF ADR IN EACH FOLLOW UP (n=21)
FIGURE13 :  DEVELOPMENT OF ADR IN EACH FOLLOW UP (n=21)
15
4
2
visit1 visit2 visit3
0
2
4
6
8
10
12
14
16
frequency
TABLE 14: DISTRIBUTION OF LEVEL OF MEDICATION ADHERENCE AMONG 
STUDY POPULATION (n=80)
S.NO NO OF 
PATIENT 
PERCENTAGE(%) 
1 visit1 15 71.5% 
2 visit2 4 19% 
3 visit3 2 9.5% 
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S.NO ADHERENCE BASELINE FOLLOW 
UP l 
FOLLOW 
UP ll
1 Low adherence
     (7-11) 
25 (31.25%) 24( 30%) 16 (20%) 
2 Medium 
adherence
        (4-6) 
36 (45%) 39( 48.75%) 37 (46.25%) 
3 High adherence
         ( 0-3) 
19(23.75%) 17 (21.25%) 27 ( 33.75%) 
FIG 14: DISTRIBUTION OF LEVEL OF MEDICATION ADHERENCE AMONG 
STUDY POPULATION (n=80)
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TABLE 15 :BASELINE  MEDICATION ADHERENCE SCORE VS  VISIT1 AND VISIT2
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 FIGURE 15 :BASELINE  MEDICATION ADHERENCE SCORE VS  FOLLOW UP l
  
   FIGURE 16 :BASELINE  MEDICATION ADHERENCE SCORE VS  FOLLOW UP ll
Mean Std .deviation P value Significance 
Visit1 1.64 .75 .008 Significant 
Visit2 1.98 .67 .000 Significant 
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TABLE16 : Medication adherence  on TB to demographic characteristics (n=80)
n % Mean SD P 
value
Male 61 76%Gender
Female 19 24%
1.62
.
.818
.000
16-30 9
11.25%
31-45 18
22.5%
46-60 33
41.25%
Age 
61-75 20
25%
-.400 1.165 .003
Pulmonary 63
78.8%
Pleural 11
11.8%
Rib 2
2.5%
Meningitis 3
3.8%
Type of TB
Lymph 1
1.2%
1.050 1.113 .000
Illiterate 25 31.2%
School 31 38.8%
Pre-
university
18 22.5%
Education 
University 6 7.5%
1.67 .756 .0
single 7
91.2%
Marital 
status
Marital 73
8.8%
.487 .763 .000
Inpatient 52
35%
Patient 
type
Outpatient 28
65%
1.050 .825 .000
51.2
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Smokers 39
Smoking 
status
Non 
smokers
41 48.8 .888 .871 .000
Daily wager 17 21.2%
Student 3 3.8%
Business 11 13.8%
private –
service 
18 22.5%
Farmer 18 22.5%
Occupation 
Unemployed 13 16.2%
-1.425 1.954 .000
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TABLE 17: DISTRIBUTION OF KNOWLEDGE  LEVEL AMONG STUDY 
POPULATION (n=80)
S.NO PATIENT 
KNOWLEDGE 
VISIT 1 VISIT 2 VISIT 3 
1 Poor knowledge 
     (o-3) 
42 (52.5%) 19( 23.75%) 11 (13.75%) 
2 Moderate 
knowledge 
        (4-6) 
25 (31.25%) 44( 55%) 26 (32.5%) 
3 Good knowledge 
         ( 7-10) 
13(16.25%) 17 (21.25%) 43 (53.75%) 
FIGURE 17: DISTRIBUTION OF KNOWLEDGE  LEVEL AMONG STUDY 
POPULATION (n=80)
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TABLE 18:Knowledge score of visit 1 and visit 2 by visit 3 knowledge score
Mean Std .deviation P value Significance 
Visit1 1.64 .75 .008 Significant 
Visit2 1.98 .67 .000 Significant 
FIG 18: Knowledge score of visit 1  by visit 3 knowledge score
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    FIG19 : Knowledge score of visit 12 by visit 3 knowledge score
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              TABLE 19:  Knowledge on TB to demographic characteristics (n=80)
Independent 
variables
Variable 
categories
n % Mean SD P 
value
Male 61 76%Gender
Female 19 24%
.900 .789 .000
16-30 9
11.25%
31-45 18
22.5%
46-60 33
41.25%
Age 
61-75 20
25%
-.662 1.169 .000
Pulmonary 63
78.8%
Pleural 11
11.8%
Rib 2
2.5%
Meningitis 3
3.8%
Type of TB
Lymph 1
1.2%
.788 1.110
.000
Illiterate 25 31.2%
School 31 38.8%
Pre-
university
18 22.5%
Education 
University 6 7.5%
1.16 .750 .042
Single 7
91.2%
Marital 
status
Marital 73
8.8%
.225 .746 .009
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Inpatient 52
35%
Patient type
Outpatient  28
65%
.788 .852
.000
Smokers 39 51.2
Non 
smokers 
41 48.8 .625 .802 .000
Daily wager 17 21.2%
Student 3 3.8%
Business 11 13.8%
.000
Farmer 18 22.5%
Occupation 
Unemployed 18 22.5%
1.688 1.940
13 16.2%
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   TABLE 20: Comparison  of Knowledge and Medication adherence score 
Mean Standard 
deviation 
P value significance
Baseline 2,25 .697 0.00 Significant 
Follow up 1st 3.97 .811 0.00 Significant 
Follow up 2nd 4.69 .882 0.009 Significant 
FIG 20: Comparision  of Knowledge and Medication adherence score 
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CONCLUSION
This study was principally emphasized in absolute care of Tuberculosis patients 
throughout their intensive phase of therapy by providing a knowledge based approach to 
improve the drug adherence and reducing severity of drug related problems.
Entirely 80 patient were included in the study. Tuberculosis was predominant in males. In 
this study found that TB occurred chiefly in age group ’46-60’. Majority of them had   
PTB. Most of the patients presented with cardinal sign of TB such as cough. In   my  study 
all the patients got counselling with the help of pamphlet and knowledge was assessed by 
giving the knowledge assessment questionnaire and the  medication adherence assessed by 
Morisky medication adherence scale.
Patient education and medication counseling are essential components in the management 
of TB. Medication adherence can be achieved by educating the patient about the disease 
and drugs and their use,
In conclusion, patient educaton had most impact on medication adherence, Medication 
adherence was improved after counseling of patients. By this, the study concluded that 
patient education and medication counseling improved adherence and improved their 
therapy outcome.
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